Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy-Reference-Cited by-同舟云学术

Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy

Published:2009-03 Issue:3 Volume:53 Page:1287-1289
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Yagci D.¹,Yoruk F.¹,Azap A.¹,Memikoglu O.¹

Affiliation:

1. Ankara University, School of Medicine, Department of Clinical Microbiology and Infectious Diseases, Ankara, Turkey

Abstract

ABSTRACT Patients taking quinolones as inpatients ( n = 55) or outpatients ( n = 40) and newly hospitalized patients who were not on quinolone therapy ( n = 41) were assessed for fecal carriage of quinolone-resistant Escherichia coli (QREC) strains before and after therapy/hospitalization. Fluoroquinolone use in the previous 6 months was found to be a risk factor for QREC carriage before therapy/hospitalization. The prevalence of QREC strains in fecal flora increased steadily with the duration of quinolone therapy.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01228-08

Reference12 articles.

1. K-1415. 46th Intersci. Conf. Antimicrob. Agents Chemother. 2006

2. Arslan, H., O. K. Azap, O. Ergonul, and F. Timurkaynak. 2005. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J. Antimicrob. Chemother.56:914-918.

3. Bearden, D. T., and L. H. Danziger. 2001. Mechanism of action of and resistance to quinolones. Pharmacotherapy21:224-232.

4. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

5. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. 2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Drug-Specific Propensity Regarding the Acquisition of Fluoroquinolone Resistance in Escherichia coli: An in vitro Challenge and DNA Mutation Analysis;Infection and Drug Resistance;2023-09

2. Fluoroquinolone Use Among Hospitalized Children: Diagnosis-Based Stratification to Identify Stewardship Targets;Open Forum Infectious Diseases;2023-05-29

3. Efficacy of Single Dose of Fosfomycin Versus a Five-Day Course of Ciprofloxacin in Patients With Uncomplicated Urinary Tract Infection;Cureus;2022-05-09

4. Estimating the cost of antibiotic use on future collateral resistance: a retrospective comparison of cefuroxime versus cefazolin and amoxicillin/clavulanate;2022-01-11

5. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy;UROL J;2020